Madrigal Pharmaceuticals had a revenue of 137.25M in the quarter ending Mar 31, 2025, with 32.84%. This bring the company's revenue in the last twelve months to 317.38M, Decreased 76.19%. In the fiscal year ending Dec 31, 2024, Madrigal Pharmaceuticals had annual revenue of 180.13M with Infinity% growth.